Serum Npas-4 and Nptx-2 Levels in Alzheimer’s Disease: Potential Biomarkers of Synaptic Dysfunction in a Cross-Sectional Study. This evidence concerns the gene NPTX2 and early-onset autosomal dominant Alzheimer disease.